Absci Corporation (ABSI)
ABSI moved a median of +0.34% 30 minutes after news, and +0.64% by the close. How ABSI actually reacts to news — the realized, point-in-time move the market made, measured across 287 labeled events over the last three years with zero look-ahead.
ABSI’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | +0.15% | 54% | 287 |
| 30-min | +0.34% | 53% | 287 |
| 60-min | +0.12% | 52% | 287 |
| to close | +0.64% | 53% | 280 |
| Middle 50% of ABSI reactions | -2.00% to +2.33% |
|---|---|
| Median reaction (30-min) | +0.34% |
| Measured reactions | 287 |
Half of all Absci Corporation news events land between -2.00% and +2.33% at 30 minutes.
Reaction stats as of 2026-08-31. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How ABSI reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Coverage initiations | 27 | -1.13% | 33% | +2.42% |
| Rating reiterations | 67 | +0.53% | 55% | -0.54% |
Last 3 years, pulled 2026-08-31. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 4 further classes were observed with fewer than 10 measured events and are not published. See how ABSI ranks against every other measured name →
That’s how ABSI usually reacts — get an email when it moves on news →Email me when ABSI moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to ABSI's baseline. Nothing else.
Recent ABSI events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Absci to Participate in Upcoming Investor Conferences | Press release | GlobeNewswire | +1.58% | -0.11% | |
| Absci Reports Business Updates and Second Quarter 2026 Financial and Operating Results | Press release | GlobeNewswire | +2.90% | +6.03% | |
| Form 10-Q Absci Corp For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +2.90% | +6.03% | |
| Form 8-K Absci Corp For: Aug 11 | SEC filing · Form 8-K | SEC EDGAR | +2.90% | +6.03% | |
| A Small AI Company Just Took the Stage at One of the Biggest Events in Computing, and It Points to Where Drug Discovery Is Headed | Press release | Canada Newswire | -1.23% | -7.01% | |
| Absci to Report Business Updates and Second Quarter 2026 Financial and Operating Results on August 11, 2026 | Press release | GlobeNewswire | -2.32% | -5.79% | |
| As AI Models Become Commodities, a Bio-Native AI Company Just Moved to Patent the Data Layer Beneath the Models | Press release | Canada Newswire | +0.26% | -0.77% | |
| The Quantum Sector Hits an Inflection Point: Federal Money, Real Milestones, and a Security Race Running in Parallel | Press release | PR Newswire | +0.26% | -0.77% | |
| Absci Announces Positive Interim Phase 1 Data from the HEADLINE™ Trial of ABS-201, a Novel Antibody Targeting the Prolactin Receptor (PRLR) | Press release | GlobeNewswire | +11.15% | +5.94% | |
| Absci Announces Pricing of $100 Million Underwritten Offering with Leading Strategic and Financial Investors | Press release | GlobeNewswire | +11.15% | +5.94% | |
| Form 8-K Absci Corp For: Jun 24 | SEC filing · Form 8-K | SEC EDGAR | +11.15% | +5.94% | |
| The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It | Press release | Canada Newswire | -3.22% | -3.98% | |
| Form 8-K Absci Corp For: Jun 04 | SEC filing · Form 8-K | SEC EDGAR | -1.20% | -1.50% | |
| Absci to Participate in Upcoming Investor Conferences | Press release | GlobeNewswire | +1.07% | +5.77% | |
| Absci Reports Business Updates and First Quarter 2026 Financial and Operating Results | Press release | GlobeNewswire | +0.70% | +17.30% | |
| Form 10-Q Absci Corp For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +0.70% | +17.30% | |
| Form 8-K Absci Corp For: May 07 | SEC filing · Form 8-K | SEC EDGAR | +0.70% | +17.30% | |
| Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | Press release | GlobeNewswire | -0.14% | +0.18% | |
| Absci to Report Business Updates and First Quarter 2026 Financial and Operating Results on May 7, 2026 | Press release | GlobeNewswire | -0.76% | -0.76% | |
| Form ARS Absci Corp For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | +1.10% | +8.77% | |
| Form DEF 14A Absci Corp For: Apr 22 | SEC filing · Form DEF | SEC EDGAR | +1.10% | +8.77% | |
| Form DEFA14A Absci Corp | SEC filing · Form DEFA14A | SEC EDGAR | +1.10% | +8.77% | |
| Absci to Participate in the 25th Annual Needham Virtual Healthcare Conference | Press release | GlobeNewswire | -0.82% | -2.29% | |
| Absci Launches ABS-201 Endometriosis Advisory Board with Leading Experts from Yale, UCSF, Duke, and the Mayo Clinic | Press release | GlobeNewswire | +1.38% | +3.79% | |
| Absci Reports Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results | Press release | GlobeNewswire | +3.45% | +0.69% | |
| Form 10-K Absci Corp For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +3.45% | +0.69% | |
| Form 8-K Absci Corp For: Mar 24 | SEC filing · Form 8-K | SEC EDGAR | +3.45% | +0.69% | |
| Form S-8 Absci Corp | SEC filing · Form S-8 | SEC EDGAR | +3.45% | +0.69% | |
| Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | Press release | GlobeNewswire | +2.60% | +8.66% | |
| Form 8-K Absci Corp For: Mar 03 | SEC filing · Form 8-K | SEC EDGAR | +2.60% | +8.66% | |
| Absci Strengthens Clinical Leadership with Appointment of Ransi Somaratne, M.D., FACC, MBA as Chief Medical Officer | Press release | GlobeNewswire | -0.38% | -2.65% | |
| Absci to Report Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results on March 24, 2026 | Press release | GlobeNewswire | +0.11% | +3.04% | |
| Absci to Participate in Upcoming Investor Conferences | Press release | GlobeNewswire | +0.79% | +4.72% | |
| Form 8-K Absci Corp For: Jan 14 | SEC filing · Form 8-K | SEC EDGAR | -1.25% | -8.68% | |
| Absci to Participate in the 44th Annual J.P. Morgan Healthcare Conference | Press release | GlobeNewswire | +2.37% | +5.34% | |
| AI Creation Engines Transform Biotech as Wellness Tech Captures Growth Wave | Press release | PR Newswire | +0.04% | -1.58% | |
| Absci Reports New Human Ex Vivo Data Demonstrating That ABS-201™ Stimulates Hair Growth and Regenerates Stem Cell Niche to Potentially Reverse Follicle Miniaturization | Press release | GlobeNewswire | -0.26% | -2.04% | |
| Absci and U.S. Soccer Legend Landon Donovan Partner to Champion the Patient Voice in Hair Loss Research | Press release | GlobeNewswire | +2.01% | +6.43% | |
| Absci Announces First Participants Dosed in Phase 1/2a HEADLINE™ Trial of AI-Designed Antibody ABS-201™ for Androgenetic Alopecia | Press release | GlobeNewswire | +6.21% | +13.03% | |
| Absci Reports Business Updates and Third Quarter 2025 Financial and Operating Results | Press release | GlobeNewswire | -5.17% | — | |
| Form 10-Q Absci Corp For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | -5.17% | — | |
| Form 8-K Absci Corp For: Nov 12 | SEC filing · Form 8-K | SEC EDGAR | -5.17% | — | |
| Form 8-K Absci Corp For: Oct 31 | SEC filing · Form 8-K | SEC EDGAR | -1.54% | -2.31% | |
| Absci to Report Business Updates and Third Quarter 2025 Financial and Operating Results on November 12, 2025 | Press release | GlobeNewswire | +1.30% | -3.08% | |
| Absci to Participate in Upcoming Investor Conferences | Press release | GlobeNewswire | -0.02% | +3.45% | |
| Absci to Host KOL Seminar on ABS-201 Androgenetic Alopecia Program on December 11, 2025; Announces Accelerated Initiation of Phase 1/2a Trial | Press release | GlobeNewswire | +9.28% | +23.76% | |
| Absci Accelerates AI-Driven Drug Discovery with Oracle and AMD | Press release | GlobeNewswire | +5.00% | +9.60% | |
| Absci Expands ABS-201 Scientific Advisory Board with Addition of Leading Dermatology Experts Dr. Rodney Sinclair and Dr. David Goldberg | Press release | GlobeNewswire | +0.59% | +0.00% | |
| Form EFFECT Absci Corp | SEC filing · Form EFFECT | SEC EDGAR | +0.74% | -2.68% | |
| Absci to Participate in Upcoming Investor Conferences | Press release | GlobeNewswire | -0.57% | -3.02% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the ABSI section they belong to.
Where else ABSI is measured.
ABSI earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Absci Corporation's median reaction calculated?
Every labeled ABSI news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 287 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 53% of ABSI's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-08-31.
Does ABSI's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.